Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | AZN | AMGN | GILD | BMY |
| Company | Recursion Pharmaceuticals Inc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.41 | 190.67 | 359.82 | 143.16 | 59.35 |
| High | 3.50 | 190.73 | 360.68 | 143.79 | 59.67 |
| Low | 3.30 | 187.56 | 350.81 | 139.23 | 58.81 |
| Latest | 3.32 | 188.42 | 351.48 | 141.29 | 59.37 |
| Change | -0.10 | -2.87 | -9.65 | -3.11 | -0.34 |
| % Change | -2.92% | -1.50% | -2.67% | -2.15% | -0.57% |
| Volume | 14,500,199 | 1,174,400 | 2,895,400 | 7,079,600 | 12,538,900 |
| 20-Day Average Volume | 16,019,045 | 1,865,795 | 2,512,500 | 6,434,485 | 12,398,215 |
| Previous Close | 3.42 | 191.29 | 361.13 | 144.40 | 59.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.52 | 198.94 | 374.32 | 146.86 | 60.65 |
| 20-Day Raw Stochastic | 11.63% | 3.84% | 1.66% | 14.69% | 22.99% |
| 20-Day Relative Strength | 39.94 | 42.75 | 43.39 | 47.13 | 51.64 |
| Weighted Alpha | -53.51 | +27.72 | +16.13 | +34.59 | +9.56 |
| Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 80% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.77% since 03/11/26 | -2.53% since 03/11/26 | -6.93% since 03/11/26 | -3.23% since 03/11/26 | -1.02% since 03/11/26 |
| Low | 3.22 on 03/12/26 | 187.56 on 03/18/26 | 350.81 on 03/18/26 | 139.23 on 03/18/26 | 58.32 on 03/12/26 |
| High | 3.52 on 03/13/26 | 193.96 on 03/17/26 | 375.00 on 03/12/26 | 148.22 on 03/13/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | -5.95% since 02/18/26 | -9.70% since 02/18/26 | -7.44% since 02/18/26 | -7.50% since 02/18/26 | -0.60% since 02/18/26 |
| Low | 3.22 on 03/12/26 | 187.56 on 03/18/26 | 350.81 on 03/18/26 | 139.23 on 03/18/26 | 58.32 on 03/12/26 |
| High | 4.08 on 02/25/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -25.23% since 12/18/25 | +3.97% since 12/18/25 | +8.34% since 12/18/25 | +16.32% since 12/18/25 | +11.33% since 12/18/25 |
| Low | 2.98 on 02/18/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 5.24 on 01/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -32.66% since 09/18/25 | +22.24% since 09/18/25 | +27.43% since 09/18/25 | +24.35% since 09/18/25 | +30.20% since 09/18/25 |
| Low | 2.98 on 02/18/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 7.18 on 10/20/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,803,701 | 296,673,184 | 194,673,616 | 179,261,184 | 121,597,856 |
| Shares Outstanding, K | 527,398 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 74,680,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -644,760,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 35,540,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -108,120,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.97 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/25/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/04/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.96 | 16.76 | 17.82 | 9.71 |